Cargando…

Prevalence of hypermutators among clinical Acinetobacter baumannii isolates

OBJECTIVES: The objectives of this study were to study the presence of mutators in a set of Acinetobacter baumannii isolates and to explore whether there is a correlation between mutation rates and antibiotic resistance. METHODS: The variation in mutation rate was evaluated for 237 clinical A. bauma...

Descripción completa

Detalles Bibliográficos
Autores principales: Komp Lindgren, Patricia, Higgins, Paul G., Seifert, Harald, Cars, Otto
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Oxford University Press 2016
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4743697/
https://www.ncbi.nlm.nih.gov/pubmed/26660878
http://dx.doi.org/10.1093/jac/dkv378
_version_ 1782414391609655296
author Komp Lindgren, Patricia
Higgins, Paul G.
Seifert, Harald
Cars, Otto
author_facet Komp Lindgren, Patricia
Higgins, Paul G.
Seifert, Harald
Cars, Otto
author_sort Komp Lindgren, Patricia
collection PubMed
description OBJECTIVES: The objectives of this study were to study the presence of mutators in a set of Acinetobacter baumannii isolates and to explore whether there is a correlation between mutation rates and antibiotic resistance. METHODS: The variation in mutation rate was evaluated for 237 clinical A. baumannii isolates by determining the frequency of their mutation to rifampicin resistance. For each isolate, the antibiotic resistance profile was determined by disc diffusion and/or Etest. Isolates were divided into susceptible, resistant and MDR groups according to their resistance to five groups of different antibiotics. A comparison between differences in mutation frequency (f) and strain-specific factors was performed. RESULTS: Of the 237 isolates 32%, 18% and 50% were classified as susceptible, resistant and MDR, respectively. The f of rifampicin resistance varied between 2.2 × 10(−10) and 1.2 × 10(−6). Of the strains under investigation, 16% had an ≥2.5- to 166-fold higher f. The presence of mutators (definition ≥2.5-fold increase in f compared with ATCC 19606) in the MDR group (22%) was significantly higher (P < 0.05) than that in the susceptible and resistant groups (11% and 7%, respectively). Furthermore, f was significantly higher in the MDR group compared with that in the susceptible and resistant groups. CONCLUSIONS: The facts that 26 of 37 mutator isolates (70%) in the population were MDR and that there was a significantly higher general f in isolates exhibiting an MDR profile suggest that hypermutability can be of advantage for the organism in a selective environment with extensive exposure to antimicrobials.
format Online
Article
Text
id pubmed-4743697
institution National Center for Biotechnology Information
language English
publishDate 2016
publisher Oxford University Press
record_format MEDLINE/PubMed
spelling pubmed-47436972016-02-08 Prevalence of hypermutators among clinical Acinetobacter baumannii isolates Komp Lindgren, Patricia Higgins, Paul G. Seifert, Harald Cars, Otto J Antimicrob Chemother Original Research OBJECTIVES: The objectives of this study were to study the presence of mutators in a set of Acinetobacter baumannii isolates and to explore whether there is a correlation between mutation rates and antibiotic resistance. METHODS: The variation in mutation rate was evaluated for 237 clinical A. baumannii isolates by determining the frequency of their mutation to rifampicin resistance. For each isolate, the antibiotic resistance profile was determined by disc diffusion and/or Etest. Isolates were divided into susceptible, resistant and MDR groups according to their resistance to five groups of different antibiotics. A comparison between differences in mutation frequency (f) and strain-specific factors was performed. RESULTS: Of the 237 isolates 32%, 18% and 50% were classified as susceptible, resistant and MDR, respectively. The f of rifampicin resistance varied between 2.2 × 10(−10) and 1.2 × 10(−6). Of the strains under investigation, 16% had an ≥2.5- to 166-fold higher f. The presence of mutators (definition ≥2.5-fold increase in f compared with ATCC 19606) in the MDR group (22%) was significantly higher (P < 0.05) than that in the susceptible and resistant groups (11% and 7%, respectively). Furthermore, f was significantly higher in the MDR group compared with that in the susceptible and resistant groups. CONCLUSIONS: The facts that 26 of 37 mutator isolates (70%) in the population were MDR and that there was a significantly higher general f in isolates exhibiting an MDR profile suggest that hypermutability can be of advantage for the organism in a selective environment with extensive exposure to antimicrobials. Oxford University Press 2016-03 2015-12-09 /pmc/articles/PMC4743697/ /pubmed/26660878 http://dx.doi.org/10.1093/jac/dkv378 Text en © The Author 2015. Published by Oxford University Press on behalf of the British Society for Antimicrobial Chemotherapy. http://creativecommons.org/licenses/by-nc/4.0/ This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/4.0/), which permits non-commercial re-use, distribution, and reproduction in any medium, provided the original work is properly cited. For commercial re-use, please contact journals.permissions@oup.com
spellingShingle Original Research
Komp Lindgren, Patricia
Higgins, Paul G.
Seifert, Harald
Cars, Otto
Prevalence of hypermutators among clinical Acinetobacter baumannii isolates
title Prevalence of hypermutators among clinical Acinetobacter baumannii isolates
title_full Prevalence of hypermutators among clinical Acinetobacter baumannii isolates
title_fullStr Prevalence of hypermutators among clinical Acinetobacter baumannii isolates
title_full_unstemmed Prevalence of hypermutators among clinical Acinetobacter baumannii isolates
title_short Prevalence of hypermutators among clinical Acinetobacter baumannii isolates
title_sort prevalence of hypermutators among clinical acinetobacter baumannii isolates
topic Original Research
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4743697/
https://www.ncbi.nlm.nih.gov/pubmed/26660878
http://dx.doi.org/10.1093/jac/dkv378
work_keys_str_mv AT komplindgrenpatricia prevalenceofhypermutatorsamongclinicalacinetobacterbaumanniiisolates
AT higginspaulg prevalenceofhypermutatorsamongclinicalacinetobacterbaumanniiisolates
AT seifertharald prevalenceofhypermutatorsamongclinicalacinetobacterbaumanniiisolates
AT carsotto prevalenceofhypermutatorsamongclinicalacinetobacterbaumanniiisolates